| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3808906 | Medicine - Programa de Formación Médica Continuada Acreditado | 2013 | 14 Pages |
Abstract
Related arthritis inflammatory bowel disease (IBD) is presented by 9-53% of patients, in mono or oligoarticular, asymmetric and predominantly in the lower limbs. The use of NSAIDs is the first therapeutic step. The disease-modifying drugs, such as sulfasalazine, are effective in refractory patients. Biological therapy with anti-TNF-alpha has been shown to be highly effective in patients refractory.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
R. Almodóvar González, P. Zarco Montejo,